Skip to main content

DNA Archives

Carcinogenic chemicals cramp DNA

Nov. 21, 2012—Researchers have determined how a DNA lesion caused by exposure to chemicals may spark cancer formation.

Read more


Genomic research gains ad-“vantage” with new resources

Nov. 1, 2012—Vanderbilt University Medical Center has stepped up its support of research aimed at cracking the mysteries of the genome, the master DNA code.

Read more


VU recruit’s work lights up genetic ‘dark matter’

Oct. 11, 2012—They’ve been called “junk DNA” and genetic “dark matter” — the long segments of the human genome (98 percent of it) that do not encode protein.

Read more


BioVU reaches new benchmark in DNA samples

Sep. 6, 2012—This month BioVU logged in its 150,000th unique genetic sample. It is now the world’s largest collection of human DNA linked to searchable, electronic health information.

Read more


Kids’ cells okay after mom’s cancer radiation

Jun. 22, 2012—Study finds no evidence of increased mitochondrial mutations in the children of women treated with radiation for cancer.

Read more


Gene database to aid disease research

Jun. 19, 2012—A new catalog of human genetic data may help researchers uncover the genetic roots of disease and enable the ultimate realization of personalized medicine.

Read more


Vanderbilt identifies genes linked to breast cancer chemo resistance

Jun. 11, 2012—A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.

Read more


DNA: From modification to mutation

Jun. 8, 2012—Understanding how an environmental hazard damages DNA may shed light on processes of tumor formation.

Read more


iPOND method goes fishing for proteins

Mar. 19, 2012—A new tool will allow researchers to identify proteins involved in DNA replication and damage repair, processes that go awry in cancer.

Read more


‘Detangler’ binds, bends and cuts DNA

Mar. 2, 2012—New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents.

Read more


Fungus toxin gets in the way in DNA

Oct. 7, 2011—Structural studies are providing insight to how aflatoxin – a toxin produced by fungi – contributes to cancer development.

Read more


The Possibilities of Personalized Medicine

Jan. 31, 2010—What if your doctor could tell by reading your genetic code which drugs were most likely to work for you, and which you should avoid, even before you try them? What if a “genetic biopsy” taken from your cancer could pinpoint the treatment most likely to kill the tumor, and with the fewest side effects?...

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more